BACKGROUND. Percutaneous transluminal angioplasty has been adopted widely as a treatment for patients with peripheral vascular disease of the lower extremities. However, the effect of this procedure on the overall management of peripheral vascular disease and on the outcomes of patients has not been clearly delineated. In particular, it is not known whether angioplasty has replaced other treatments for peripheral vascular disease. METHODS. To assess the extent to which angioplasty is used and the associated changes in the surgical management of peripheral vascular disease of the lower extremities, we used data on hospital discharges in Maryland to identify all angioplasty procedures, peripheral bypass operations, and lower-extremity amputations performed for peripheral vascular disease in Maryland hospitals between 1979 and 1989. RESULTS. We estimated that from 1979 to 1989 the annual rate of percutaneous transluminal angioplasty for peripheral vascular disease of the lower extremities, adjusted for age and sex, rose from 1 to 24 per 100,000 Maryland residents (P less than 0.0001 by linear regression). Despite this increase in the use of angioplasty, the adjusted annual rate of peripheral bypass surgery also rose substantially, from 32 to 65 per 100,000 (P less than 0.001), whereas the adjusted annual rate of lower-extremity amputation remained stable at about 30 per 100,000. Total charges for hospitalizations during which a peripheral revascularization procedure was performed increased from $14.7 million in 1979 (in 1989 dollars) to $30.5 million in 1989. CONCLUSIONS. In Maryland, the adoption of percutaneous transluminal angioplasty for peripheral vascular disease of the lower extremities has been associated with an increase in the use of peripheral bypass surgery and with no decline in lower-extremity amputations. These results could be due to increased diagnosis of peripheral vascular disease, expanded indications for procedural interventions, or an increased number of repeat procedures performed in patients with peripheral vascular disease of the lower extremities.
Source Information
Johns Hopkins Program for Medical Technology and Practice Assessment, Baltimore, MD 21205.
This article has been cited by other articles:
Karamlou, T., Diggs, B. S., Ungerleider, R. M., McCrindle, B. W., Welke, K. F.
(2008). The Rush to Atrial Septal Defect Closure: Is the Introduction of Percutaneous Closure Driving Utilization?. Ann. Thorac. Surg.
86: 1584-1591
[Abstract][Full Text]
Hirsch, A. T, Hartman, L., Town, R. J, Virnig, B. A
(2008). National health care costs of peripheral arterial disease in the Medicare population. Vasc Med
13: 209-215
[Abstract]
Pipinos, I. I., Judge, A. R., Selsby, J. T., Zhen Zhu, , Swanson, S. A., Nella, A. A., Dodd, S. L.
(2008). The Myopathy of Peripheral Arterial Occlusive Disease: Part 1. Functional and Histomorphological Changes and Evidence for Mitochondrial Dysfunction. VASC ENDOVASCULAR SURG
41: 481-489
[Abstract]
Heredero, A. F., Acin, F., March, J. R., Utrilla, F.
(2005). Impact of Endovascular Surgery on Management of Critical Lower-Limb Ischemia in a Vascular Surgery Department. VASC ENDOVASCULAR SURG
39: 429-435
[Abstract]
Aulivola, B., Hile, C. N., Hamdan, A. D., Sheahan, M. G., Veraldi, J. R., Skillman, J. J., Campbell, D. R., Scovell, S. D., LoGerfo, F. W., Pomposelli, F. B. Jr
(2004). Major Lower Extremity Amputation: Outcome of a Modern Series. Arch Surg
139: 395-399
[Abstract][Full Text]
Lepantalo, M., Tukiainen, E.
(2002). Advanced Leg Salvage. PERSPECT VASC SURG ENDOVASC THER
15: 27-41
[Abstract]
Jude, E. B., Oyibo, S. O., Chalmers, N., Boulton, A. J.M.
(2001). Peripheral Arterial Disease in Diabetic and Nondiabetic Patients: A comparison of severity and outcome. Diabetes Care
24: 1433-1437
[Abstract][Full Text]
Wrobel, J. S., Mayfield, J. A., Reiber, G. E.
(2001). Geographic Variation of Lower-Extremity Major Amputation in Individuals With and Without Diabetes in the Medicare Population. Diabetes Care
24: 860-864
[Abstract][Full Text]
Hsia, J., Simon, J. A., Lin, F., Applegate, W. B., Vogt, M. T., Hunninghake, D., Carr, M.
(2000). Peripheral Arterial Disease in Randomized Trial of Estrogen With Progestin in Women With Coronary Heart Disease : The Heart and Estrogen/Progestin Replacement Study. Circulation
102: 2228-2232
[Abstract][Full Text]
Pronovost, P. J., Jenckes, M. W., Dorman, T., Garrett, E., Breslow, M. J., Rosenfeld, B. A., Lipsett, P. A., Bass, E.
(1999). Organizational Characteristics of Intensive Care Units Related to Outcomes of Abdominal Aortic Surgery. JAMA
281: 1310-1317
[Abstract][Full Text]
Weitz, J. I., Byrne, J., Clagett, G. P., Farkouh, M. E., Porter, J. M., Sackett, D. L., Strandness, D. E., Taylor, L. M.
(1996). Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review. Circulation
94: 3026-3049
[Full Text]
Pasini, F. L., Pastorelli, M., Beermann, U., de Candia, S., Gallo, S., Blardi, P., Di Perri, T.
(1996). Peripheral Neuropathy Associated with Ischemic Vascular Disease of the Lower Limbs. ANGIOLOGY
47: 569-577
[Abstract]
Gardner, A. W., Poehlman, E. T.
(1995). Exercise Rehabilitation Programs for the Treatment of Claudication Pain: A Meta-analysis. JAMA
274: 975-980
[Abstract]
Hiatt, W. R., Hirsch, A. T., Regensteiner, J. G., Brass, E. P.
(1995). Clinical Trials for Claudication : Assessment of Exercise Performance, Functional Status, and Clinical End Points. Circulation
92: 614-621
[Full Text]
Hunink, M. G. M., Wong, J. B., Donaldson, M. C., Meyerovitz, M. F., de Vries, J., Harrington, D. P.
(1995). Revascularization for Femoropopliteal Disease: A Decision and Cost-effectiveness Analysis. JAMA
274: 165-171
[Abstract]
Hunink, M. G.M., Wong, J. B., Donaldson, M. C., Meyerovitz, M. F., Harrington, D. P.
(1994). Patency Results of Percutaneous and Surgical Revascularization for Femoropopliteal Arterial Disease. Med Decis Making
14: 71-81
[Abstract]
Gonschior, P., Hofling, B., Mack, B., Simpson, L., Gerheuser, F., Nerlich, A., Bauriedel, G., Welsch, U.
(1993). Results of Directional Peripheral Atherectomy with Reference to Histology, Histochemistry, and Ultrastructure. ANGIOLOGY
44: 454-463
[Abstract]
Tunis, S. R., Bass, E. B., Klag, M. J., Steinberg, E. P.
(1993). Variation in Utilization of Procedures for Treatment of Peripheral Arterial Disease: A Look at Patient Characteristics. Arch Intern Med
153: 991-998
[Abstract]
Stergachis, A., Sheingold, S., Luce, B. R., Psaty, B. M., Revicki, D. A.
(1992). Medical Care and Cost Outcomes After Pentoxifylline Treatment for Peripheral Arterial Disease. Arch Intern Med
152: 1220-1224
[Abstract]
(1991). DOUBTS ABOUT PERIPHERAL ARTERIAL ANGIOPLASTY. JWatch General
1991: 2-2
[Full Text]
de Vries, S. O., Visser, K., de Vries, J. A., Wong, J. B., Donaldson, M. C., Hunink, M. G. M.
(2002). Intermittent Claudication: Cost-effectiveness of Revascularization versus Exercise Therapy. Radiology
222: 25-36
[Abstract][Full Text]